Insiders · GANX

GANX insider transactions

Gain Therapeutics Inc. (GANX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for GANX

• 73d
  SEC Form 4 filed by Mack Gene

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 73d
  SEC Form 4 filed by Fuggetta Gianluca

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 348d
  SEC Form 4 filed by Director Islam Khalid

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 348d
  SEC Form 4 filed by Director Richman Eric I

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 348d
  SEC Form 4 filed by Director Nicaise Claude

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 348d
  SEC Form 4 filed by Director Hasler Hans Peter

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 348d
  SEC Form 4 filed by Director Riley Jeffrey Scott

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 348d
  SEC Form 4 filed by Director Goldstein Dov A Md

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 348d
  SEC Form 4 filed by Director Melincoff Gwen A

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 443d
  SEC Form 4 filed by See Remark Fuggetta Gianluca

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 443d
  SEC Form 4 filed by CEO, President Mack Gene

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 516d
  SEC Form 4 filed by CEO, President Mack Gene

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 665d
  CFO and Interim CEO Mack Gene bought $14,544 worth of shares (14,400 units at $1.01) (SEC Form 4)

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 665d
  Executive Chairman Islam Khalid bought $49,940 worth of shares (50,000 units at $1.00) (SEC Form 4)

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 707d
  Director Richman Eric I bought $20,670 worth of shares (17,000 units at $1.22), increasing direct ownership by 6% to 289,629 units (SEC Form 4)

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 711d
  SEC Form 4 filed by Director Islam Khalid

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 711d
  SEC Form 4 filed by Director Hasler Hans Peter

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 711d
  SEC Form 4 filed by Director Melincoff Gwen A

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 711d
  SEC Form 4 filed by Director Nicaise Claude

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 711d
  SEC Form 4 filed by Director Goldstein Dov A Md

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 711d
  SEC Form 4 filed by Director Riley Jeffrey Scott

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 711d
  SEC Form 4 filed by Director Richman Eric I

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 790d
  SEC Form 4 filed by Mack Gene

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 790d
  SEC Form 3 filed by new insider Mack Gene

  3 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 798d
  Riley Jeffrey Scott bought $115,770 worth of shares (30,000 units at $3.86) (SEC Form 4)

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 801d
  Alder Matthias covered exercise/tax liability with 6,085 shares and converted options into 20,212 shares, increasing direct ownership by 201% to 21,140 units (SEC Form 4)

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 804d
  SEC Form 4 filed by Fuggetta Gianluca

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 804d
  SEC Form 4 filed by Alder Matthias

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 899d
  Alder Matthias converted options into 637 shares and sold $507 worth of shares (206 units at $2.46), increasing direct ownership by 9% to 5,286 units (SEC Form 4)

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 907d
  Alder Matthias sold $4,550 worth of shares (1,820 units at $2.50), decreasing direct ownership by 27% to 4,855 units (SEC Form 4)

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 979d
  Alder Matthias converted options into 825 shares, increasing direct ownership by 14% to 6,675 units (SEC Form 4)

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 990d
  SEC Form 4: Richman Eric I converted options into 54,900 shares, increasing direct ownership by 25% to 272,629 units

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 990d
  SEC Form 4: Alder Matthias converted options into 2,550 shares, increasing direct ownership by 77% to 5,850 units

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1069d
  SEC Form 4 filed by Alder Matthias

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1078d
  SEC Form 4 filed by Islam Khalid

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1078d
  SEC Form 4 filed by Riley Jeffrey Scott

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1078d
  SEC Form 4 filed by Goldstein Dov A Md

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1078d
  SEC Form 4 filed by Melincoff Gwen A

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1078d
  SEC Form 4 filed by Nicaise Claude

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1078d
  SEC Form 4 filed by Hasler Hans Peter

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1152d
  SEC Form 4 filed by Ballantyne Charles Evan

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1152d
  SEC Form 3 filed by new insider Ballantyne Charles Evan

  3 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1169d
  SEC Form 4 filed by Calabrese Salvatore

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1169d
  SEC Form 4 filed by Fuggetta Gianluca

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1169d
  SEC Form 4 filed by Alder Matthias

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1265d
  SEC Form 3 filed by new insider Fuggetta Gianluca

  3 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1355d
  SEC Form 4 filed by Richman Eric I

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1355d
  SEC Form 4 filed by Islam Khalid

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1355d
  SEC Form 4 filed by Riley Jeffrey Scott

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1355d
  SEC Form 4 filed by Goldstein Dov A Md

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1355d
  SEC Form 4 filed by Melincoff Gwen A

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1355d
  SEC Form 4 filed by Nicaise Claude

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1355d
  SEC Form 4 filed by Hasler Hans Peter

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1355d
  SEC Form 4 filed by Alder Matthias

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1420d
  SEC Form 4 filed by Calabrese Salvatore

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1420d
  SEC Form 4 filed by Alder Matthias

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1473d
  SEC Form 4: Richman Eric I bought $6,404 worth of shares (2,482 units at $2.58), increasing direct ownership by 1% to 217,729 units

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1477d
  SEC Form 4: Richman Eric I bought $10,840 worth of shares (4,000 units at $2.71) and bought $26,194 worth of shares (9,256 units at $2.83), increasing direct ownership by 7% to 215,247 units

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1477d
  SEC Form 4: Calabrese Salvatore bought $8,100 worth of shares (3,000 units at $2.70) (Amendment)

  4/A - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1481d
  SEC Form 4: Calabrese Salvatore bought $24,300,000 worth of shares (3,000 units at $8,100.00), increasing direct ownership by 59% to 8,100 units

  4 - Gain Therapeutics, Inc. (0001819411) (Issuer)